Impact of a previous cancer history on the overall survival of patients with primary gastric cancer: A SEER population-based study

被引:4
|
作者
Chen, Yuqian [1 ]
Sun, Rong [1 ]
Liu, Wanli [1 ]
机构
[1] Nanjing Univ Chinese Med, Dept Gastroenterol, Nanjing Integrated Tradit Chinese & Western Med H, 179 Xiaolingwei, Nanjing 210014, Jiangsu, Peoples R China
来源
EJSO | 2022年 / 48卷 / 10期
关键词
Previous cancer; Primary gastric cancer; Overall survival; SEER; ELIGIBILITY CRITERIA; CLINICAL ONCOLOGY; AMERICAN SOCIETY; GASTRECTOMY; DISEASE; FRIENDS;
D O I
10.1016/j.ejso.2022.06.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The impact of previous cancers on the survival of gastric cancer (GC) patients is still uncertain. To evaluate the impact of a prior cancer history on the overall survival of patients with primary GC. Methods: The Surveillance, Epidemiology, and End Results (SEER) database provided data on patients diagnosed with GC as the first or second primary malignancy between 2010 and 2015 in this retrospective cohort study. Cox proportional hazards models, Kaplan-Meier curves and forest plots were utilized to analyze overall survival. Subgroup analysis was performed based on age, gender, race and prior cancer type. Results: Totally 39,379 were eligible for this study, including 7403 (18.8%) with a previous cancer history. A previous cancer was an independent risk factor for overall survival [hazard ratio (HR) = 1.103, 95% confidence interval (CI): 1.070-1.138]. For GC patients aged 40-60 years (HR = 1.191, 95% CI: 1.084 -1.308) and >= 60 years (HR = 1.093, 95% CI: 1.058-1.13) at diagnosis, a previous cancer was significantly associated with worse overall survival. GC patients with previous oral cavity and pharynx cancer (HR = 1.249, 95% CI: 1.038-1.501), respiratory system cancer (HR = 1.177, 95% CI: 1.076-1.286), female genital system cancer (HR = 1.169, 95% CI: 1.011-1.351), or lymphoma cancer (HR = 1.192, 95% CI: 1.023 -1.389) had shorter overall survival than GC patients without a previous cancer. Conclusion: A previous cancer adversely affected the overall survival of GC patients. Specifically, GC patients aged > 40 years, or with oral cavity and pharynx cancer, respiratory system cancer, female genital system cancer, or lymphoma cancer had inferior overall survival. These patients should obtain more attention and get individualized treatment to improve prognosis, and clinical trial eligibility criteria could be reconsidered for particular age and cancer types.
引用
收藏
页码:2159 / 2165
页数:7
相关论文
共 50 条
  • [1] Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis
    Sabrina M. Ebinger
    René Warschkow
    Ignazio Tarantino
    Bruno M. Schmied
    Ulrich Güller
    Marc Schiesser
    [J]. Gastric Cancer, 2016, 19 : 723 - 734
  • [2] Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis
    Ebinger, Sabrina M.
    Warschkow, Rene
    Tarantino, Ignazio
    Schmied, Bruno M.
    Guller, Ulrich
    Schiesser, Marc
    [J]. GASTRIC CANCER, 2016, 19 (03) : 723 - 734
  • [3] Prognostic nomograms for predicting overall survival and cancer-specific survival in patients with angiosarcoma, a SEER population-based study
    Ting Jiang
    Zixiang Ye
    Tianyu Shao
    Yiyang Luo
    Binbin Wang
    [J]. Scientific Reports, 12
  • [4] Prognostic nomograms for predicting overall survival and cancer-specific survival in patients with angiosarcoma, a SEER population-based study
    Jiang, Ting
    Ye, Zixiang
    Shao, Tianyu
    Luo, Yiyang
    Wang, Binbin
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [5] The effect of a gastric second primary cancer on the survival of patients with a previous cancer history
    Morais, Samantha
    Antunes, Luis
    Bento, Maria Jose
    Lunet, Nuno
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2020, 29 (03) : 215 - 221
  • [6] Prediction of distant organ metastasis and overall survival of lung cancer patients: a SEER population-based cohort study
    Hao, Yongping
    Li, Guang
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Clinical characteristics and overall survival nomogram of second primary malignancies after prostate cancer, a SEER population-based study
    Yi Liu
    Peipei Zhang
    Yinghao Zhang
    Lichuan Zheng
    Wenbo Xu
    Dongtao Hou
    Zhengjun Kang
    [J]. Scientific Reports, 11
  • [8] Clinical characteristics and overall survival nomogram of second primary malignancies after prostate cancer, a SEER population-based study
    Liu, Yi
    Zhang, Peipei
    Zhang, Yinghao
    Zheng, Lichuan
    Xu, Wenbo
    Hou, Dongtao
    Kang, Zhengjun
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [9] Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study
    Yin, Fangxu
    Wang, Song
    Hou, Chong
    Zhang, Yiyuan
    Yang, Zhenlin
    Wang, Xiaohong
    [J]. FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [10] Impact of Irinotecan and Oxaliplatin on Overall Survival in Patients With Metastatic Colorectal Cancer: A Population-Based Study
    Lim, Howard J.
    Gill, Sharlene
    Speers, Caroline
    Melosky, Barbara
    Barnett, Jeff
    Fitzgerald, Catherine
    O'Reilly, Susan
    Kennecke, Hagen
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2009, 5 (04) : 153 - 158